Radotinib

Item number	Size	Delivery time	Price
TGM-T2328-5mg	5 mg	7 - 10 business days*	38.00€
TGM-T2328-10mg	10 mg	7 - 10 business days*	56.00€
TGM-T2328-25mg	25 mg	7 - 10 business days*	114.00€
TGM-T2328-50mg	50 mg	7 - 10 business days*	187.00€
TGM-T2328-100mg	100 mg	7 - 10 business days*	351.00€
TGM-T2328-500mg	500 mg	7 - 10 business days*	823.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Radotinib (IY-5511), and sometimes referred to by its investigational name IY5511,... more

Close menu

Product information "Radotinib"

Description: Radotinib (IY-5511), and sometimes referred to by its investigational name IY5511, is a drug for the treatment of different types of Y, most notably Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) with resistance or intolerance of other tyrosine kinase Bcr-Abl inhibitors. Target: Bcr-Abl. Smiles: Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cnccn3)c2)cc(c1)C(F)(F)F. References: Kim SH, et al. Haematologica. 2014, 99(7), 1191-1196.

Keywords:	IY-5511, Supect
Supplier:	TargetMol
Supplier-Nr:	T2328

Properties

Application:	Bcr-Abl tyrosine kinase & PDGFR inhibitor
MW:	530.5 D
Formula:	C27H21F3N8O

Database Information

CAS :	926037-48-1\| Matching products
KEGG ID :	K04363 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Radotinib"

Write a review